Amid a bois­ter­ous fundrais­ing week, Bio­Med­Part­ners airs $107M biotech fund

As the VC dol­lars con­tin­ue to dom­i­nate bio­phar­ma head­lines this week, Swiss VC group Bio­Med­Part­ners AG has an­nounced its own wind­fall: it’s raised an ad­di­tion­al …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER